Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jul 5;131(13):1618-1624.
doi: 10.4103/0366-6999.235112.

Research Progress in the Pathogenesis of Alzheimer's Disease

Affiliations
Review

Research Progress in the Pathogenesis of Alzheimer's Disease

Yi-Gang Chen. Chin Med J (Engl). .

Abstract

Objective: Alzheimer's disease (AD) is a kind of chronic degenerative disease of the central nervous system, characteristics of cognitive dysfunction, and behavioral disability. The pathological changes include the formation of senile plaques-containing beta-amyloid (Aβ), neurofibrillary tangles (NFTs), loss of neurons, and synapses. So far, the pathogenesis of AD is still unclear. This study was aimed to review the major pathogenesis of AD-related to the published AD studies in recent 20 years.

Data sources: The author retrieved information from the PubMed database up to January 2018, using various search terms and their combinations, including AD, Aβ, NFTs, pathogenesis, and genetic mutation.

Study selection: The author included data from peer-reviewed journals printed in English and Chinese on pathophysiological factors in AD. He organized these informations to explain the possible pathogenesis in AD.

Results: There are many amounts of data supporting the view that AD pathogenesis so far there mainly are Aβ toxicity, tau protein, gene mutation, synaptic damages, intermediate neurons and network abnormalities, changes in mitochondrial function, chemokines, etc., Its nosogenesis may be involved in multiple theories and involved in multiple molecular signaling pathways, including Aβ, tau protein, and synaptic anomaly; mutual relationship between the mechanisms urge jointly neuronal degeneration.

Conclusions: This review highlights the research advances in the pathogenesis of AD. Future research has needed to fully disclose the association between multiple pathogenesis at the same time to interdict multiple signaling pathways, etc.

阿尔茨海默病机制的研究进展摘要目的:阿尔茨海默病(AD)是一种慢性中枢神经系统的退行性疾病, 其特征是认知障碍和行为无能。其病理改变包括:老年斑的形成、神经原纤维缠结、神经元和突触丧失等。至今AD的发生机制仍不很清楚。该文旨在对近20年已发表的有关AD主要发生机制的研究做一综述。 资料来源:本人通过PubMed等数据库检索了截止到2018年1月的大量信息, 使用了各种检索词和其组合如AD、Aβ、神经原纤维缠结、发生机制和基因突变等。 资料选择:本人列入了许多来源于以中、英文发表于同行评议杂志上的有关AD病理生理因素的资料。 结果:许多资料表明, 迄今为止AD的发生主要与Aβ毒性、tau蛋白、基因突变、突触损伤等有关。AD的发生机制可能涉及多种理论, 包含了多条分子信号通路如Aβ、tau蛋白和突触异常等; 这些机制的相互作用共同促进了神经元的退变。 结论:该综述强调了近年来有关AD发生机制的研究进展。未来的研究应该在阻断多条信号通路的同时充分揭示AD多种发生机制间关系。.

Keywords: Alzheimer's Disease; Beta-Amyloid; Neurofibrillary Tangles; Pathogenesis.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest

Similar articles

Cited by

References

    1. Lendon CL, Ashall F, Goate AM. Exploring the etiology of Alzheimer disease using molecular genetics. JAMA. 1997;277:825–31. doi: 10.1001/jama.1997.03540340059034. - PubMed
    1. Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, Zou F, et al. Replication of CLU, CR1, and PICALM associations with Alzheimer disease. Arch Neurol. 2010;67:961–4. doi: 10.1001/archneurol.2010.147. - PMC - PubMed
    1. Feulner TM, Laws SM, Friedrich P, Wagenpfeil S, Wurst SH, Riehle C, et al. Examination of the current top candidate genes for AD in a genome-wide association study. Mol Psychiatry. 2010;15:756–66. doi: 10.1038/mp.2008.141. - PubMed
    1. Chesler EJ, Lu L, Shou S, Qu Y, Gu J, Wang J, et al. Complex trait analysis of gene expression uncovers polygenic and pleiotropic networks that modulate nervous system function. Nat Genet. 2005;37:233–42. doi: 10.1038/ng1518. - PubMed
    1. Chou PS, Wu MN, Chou MC, Chien I, Yang YH. Angiotensin-converting enzyme insertion/deletion polymorphism and the longitudinal progression of Alzheimer's disease. Geriatr Gerontol Int. 2017;17:1544–50. doi: 10.1111/ggi.12929. - PubMed